Client News

[at noodls] - WIXOM, Mich., July 25, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) ...
Posted: July 25, 2014, 7:30 pm
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
Posted: July 25, 2014, 5:42 pm
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
Posted: July 25, 2014, 5:42 pm
[GlobeNewswire] - WIXOM, Mich. -- Rockwell Medical, Inc. , a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for ...
Posted: July 25, 2014, 5:30 pm
[PR Newswire] - TEL AVIV, Israel, July 25, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (Galmed), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, ...
Posted: July 25, 2014, 12:00 pm
Posted: July 24, 2014, 10:23 pm
[PR Newswire] - VANCOUVER, British Columbia and MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the company's fiscal year from December 31 to June 30. Accordingly, DelMar will file a Transition Form 10K on or before September 30, 2014. Jeffrey Bacha, president and CEO of DelMar stated, "The change to our year end is an important step in achieving our goal of obtaining a senior exchange listing for our shares." On June 6, 2014, DelMar reached agreement with certain warrant holders to reduce the warrant exercise price from $0.80 to $0.65 per share, resulting in gross proceeds of $2,373,937.
Posted: July 24, 2014, 8:07 pm
[at noodls] - Press Release Adocia Reports Operational and Financial Results for the First Half of 2014 • Major clinical results reported on two formulations based on insulin • Sound financial position with approximately ...
Posted: July 24, 2014, 4:02 pm
Posted: July 24, 2014, 1:25 pm
[GlobeNewswire] - IRVINGTON, N.Y. -- MELA Sciences, Inc. , developer of the MelaFind(R) system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, ...
Posted: July 24, 2014, 12:00 pm
[PR Newswire] - "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties. Lyfebulb is a health and wellness company dedicated to serving the needs of chronic disease patient communities by raising awareness of unmet needs, and supporting healthy lifestyles and therapy that lead to successful disease management. The IPPF is the leading support and education foundation for patients and family members from around the world affected by pemphigus vulgaris and bullous pemphigoid - two devastating autoimmune diseases affecting the skin and mucous membranes.
Posted: July 24, 2014, 6:30 am
[at noodls] - Data on primary efficacy endpoint Leukemia-Free Survival expected end of 2015 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class ...
Posted: July 24, 2014, 6:06 am
[at noodls] - News Release FOR IMMEDIATE RELEASE BIOAMBER ANNOUNCES EXERCISE IN FULL OF UNDERWRITERS' OPTION IN CONNECTION WITH PREVIOUSLY PRICED FOLLOW-ON OFFERING MINNEAPOLIS, MN, July 23, 2014 - BioAmber Inc. (NYSE: ...
Posted: July 23, 2014, 2:21 pm
[at noodls] - NORTHBROOK, Ill., July 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results ...
Posted: July 23, 2014, 2:18 pm